Back to Search
Start Over
Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a Royal College of Radiologists' audit.
- Source :
-
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2010 Sep; Vol. 22 (7), pp. 590-601. Date of Electronic Publication: 2010 Jul 01. - Publication Year :
- 2010
-
Abstract
- Aims: To compare survival and late complications between patients treated with chemoradiotherapy and radiotherapy for locally advanced cervix cancer.<br />Materials and Methods: A Royal College of Radiologists' audit of patients treated with radiotherapy in UK cancer centres in 2001-2002. Survival, recurrence and late complications were assessed for patients grouped according to radical treatment received (radiotherapy, chemoradiotherapy, postoperative radiotherapy or chemoradiotherapy) and non-radical treatment. Late complication rates were assessed using the Franco-Italian glossary.<br />Results: Data were analysed for 1243 patients from 42 UK centres. Overall 5-year survival was 56% (any radical treatment); 44% (radical radiotherapy); 55% (chemoradiotherapy) and 71% (surgery with postoperative radiotherapy). Overall survival at 5 years was 59% (stage IB), 44% (stage IIB) and 24% (stage IIIB) for women treated with radiotherapy, and 65% (stage IB), 61% (stage IIB) and 44% (stage IIIB) for those receiving chemoradiotherapy. Cox regression showed that survival was significantly better for patients receiving chemoradiotherapy (hazard ratio=0.77, 95% confidence interval 0.60-0.98; P=0.037) compared with those receiving radiotherapy taking age, stage, pelvic node involvement and treatment delay into account. The grade 3/4 late complication rate was 8% (radiotherapy) and 10% (chemoradiotherapy). Although complications continued to develop up to 7 years after treatment for those receiving chemoradiotherapy, there was no apparent increase in overall late complications compared with radiotherapy alone when other factors were taken into account (hazard ratio=0.94, 95% confidence interval 0.71-1.245; P=0.667).<br />Discussion: The addition of chemotherapy to radiotherapy seems to have improved survival compared with radiotherapy alone for women treated in 2001-2002, without an apparent rise in late treatment complications.<br /> (Copyright (c) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.)
- Subjects :
- Adolescent
Adult
Aged
Aged, 80 and over
Bone Neoplasms mortality
Bone Neoplasms secondary
Bone Neoplasms therapy
Combined Modality Therapy
Female
Humans
Liver Neoplasms mortality
Liver Neoplasms secondary
Liver Neoplasms therapy
Lung Neoplasms mortality
Lung Neoplasms secondary
Lung Neoplasms therapy
Lymphatic Metastasis
Middle Aged
Neoplasm Recurrence, Local diagnosis
Neoplasm Recurrence, Local mortality
Neoplasm Recurrence, Local therapy
Neoplasm Staging
Pelvic Neoplasms etiology
Pelvic Neoplasms pathology
Radiation Oncology
Radiotherapy Dosage
Survival Rate
Treatment Outcome
Uterine Cervical Neoplasms pathology
Young Adult
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Brachytherapy
Medical Audit
Survivors
Uterine Cervical Neoplasms mortality
Uterine Cervical Neoplasms therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1433-2981
- Volume :
- 22
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Clinical oncology (Royal College of Radiologists (Great Britain))
- Publication Type :
- Academic Journal
- Accession number :
- 20594810
- Full Text :
- https://doi.org/10.1016/j.clon.2010.06.002